Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characteristics of incidental lower-grade glioma for treatment decision-making.

Journal of neurosurgery - 1 Mar 2023

Park Jeongman, Sim Jeongmin, Ahn Juwon, Kim Yu Jin, Hwang Sojung, Cho Kyunggi, Chang Da-Young, Jung Jin-Hwa, Moon Ju Hyung, Sung KyoungSu, Lim Jaejoon

Abstract excerpt

OBJECTIVE: Several limitations are associated with the early diagnosis and treatment of incidental lower-grade glioma (iLGG), and due to its unknown molecular features, its management is categorized as either the "wait-and-see" strategy or immediate treatment. Therefore, in this study the authors explored iLGG's clinical and molecular landscape to improve its management. METHODS: The authors retrospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 35986732
DOI: 10.3171/2022.6.JNS22967

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characteristics of incidental lower-grade glioma for treatment decision-making.PMID 35986732Read ↗

Differences in molecular characteristics and overall survival between incidental and symptomatic lower grade gliomasSemantic proximity Read ↗

Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.Semantic proximity Read ↗

Diagnostic utility of genetic alterations in distinguishing IDH-wildtype glioblastoma from lower-grade gliomas: Insight from next-generation sequencing analysis of 479 cases.Semantic proximity Read ↗

Integrated Analysis of the Clinical and Molecular Characteristics of IDH Wild-Type Gliomas in the Chinese Glioma Genome AtlasSemantic proximity Read ↗

Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium.Semantic proximity Read ↗

Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?Semantic proximity Read ↗

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade GliomaSemantic proximity Read ↗

Comparative genomic landscape of lower-grade glioma and glioblastoma.Semantic proximity Read ↗

Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.Semantic proximity Read ↗

IDH-mutant grade 4 astrocytoma: a comparison integrating the clinical, pathological, and survival features between primary and secondary patients.Semantic proximity Read ↗

[Precision Medicine for IDH-mutant Diffuse Glioma(Lower-grade Glioma)].Semantic proximity Read ↗

Molecular classification of IDH-mutant glioblastomas based on gene expression profilesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.